Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | UNC2025 |
Trade Name | |
Synonyms | UNC-2025|UNC 2025 |
Drug Descriptions |
UNC2025 inhibits FLT3 and MERTK, which may result in decreased growth of MER-dependent and FLT3-dependent tumor cells (PMID: 25068800, PMID: 30482852). |
DrugClasses | FLT3 Inhibitor 69 MERTK Inhibitor 13 |
CAS Registry Number | 1429881-91-3 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cobimetinib + UNC2025 | Cobimetinib UNC2025 | 1 | 0 |
Methotrexate + UNC2025 | Methotrexate UNC2025 | 0 | 0 |
UNC2025 | UNC2025 | 1 | 0 |
UNC2025 + Vemurafenib | UNC2025 Vemurafenib | 1 | 0 |